Cullinan's innovative approach and Zipalertinib's potential approval in 2026 position it as a promising biotech investment.

“Not My Name,” the latest from Colombian powerhouse Dago García Producciones, and “High Tide” and “Name and Surname,” both from Evidencia Films, a driving force behind a new generation of Colombian ...

Young new animation filmmakers are also leading the charge, with María Cristina Pérez developing her debut animated feature ...

A team from the American University in Cairo (AUC), led by Mohamed Salama, professor at the Institute of Global health and ...